Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

In Memoriam: Edward "Ned" Lally.

Balashova N.

Pathogens. 2020 Mar 1;9(3). pii: E177. doi: 10.3390/pathogens9030177.

2.

Aggregatibacter actinomycetemcomitans LtxA Hijacks Endocytic Trafficking Pathways in Human Lymphocytes.

Lally ET, Boesze-Battaglia K, Dhingra A, Gomez NM, Lora J, Mitchell CH, Giannakakis A, Fahim SA, Benz R, Balashova N.

Pathogens. 2020 Jan 21;9(2). pii: E74. doi: 10.3390/pathogens9020074.

3.

Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.

Chang EH, Giaquinto P, Huang J, Balashova NV, Brown AC.

Mol Oral Microbiol. 2020 Jan;35(1):29-39. doi: 10.1111/omi.12275. Epub 2019 Dec 26.

PMID:
31816197
4.

Cytotoxic activity of Kingella kingae RtxA toxin depends on post-translational acylation of lysine residues and cholesterol binding.

Osickova A, Balashova N, Masin J, Sulc M, Roderova J, Wald T, Brown AC, Koufos E, Chang EH, Giannakakis A, Lally ET, Osicka R.

Emerg Microbes Infect. 2018 Nov 7;7(1):178. doi: 10.1038/s41426-018-0179-x.

5.

Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.

Brown AC, Boesze-Battaglia K, Balashova NV, Mas Gómez N, Speicher K, Tang HY, Duszyk ME, Lally ET.

PLoS One. 2018 Oct 18;13(10):e0205871. doi: 10.1371/journal.pone.0205871. eCollection 2018.

6.

Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.

Nygren P, Balashova N, Brown AC, Kieba I, Dhingra A, Boesze-Battaglia K, Lally ET.

Cell Microbiol. 2019 Mar;21(3):e12967. doi: 10.1111/cmi.12967. Epub 2018 Nov 28.

7.

Aggregatibacter actinomycetemcomitans Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles.

Nice JB, Balashova NV, Kachlany SC, Koufos E, Krueger E, Lally ET, Brown AC.

Toxins (Basel). 2018 Oct 13;10(10). pii: E414. doi: 10.3390/toxins10100414.

8.

Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.

Balashova N, Giannakakis A, Brown AC, Koufos E, Benz R, Arakawa T, Tang HY, Lally ET.

Gene. 2018 Sep 25;672:106-114. doi: 10.1016/j.gene.2018.06.003. Epub 2018 Jun 4.

9.

Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members.

Bárcena-Uribarri I, Benz R, Winterhalter M, Zakharian E, Balashova N.

Biochim Biophys Acta. 2015 Jul;1848(7):1536-44. doi: 10.1016/j.bbamem.2015.03.036. Epub 2015 Apr 7.

10.

Major intercontinentally distributed sequence types of Kingella kingae and development of a rapid molecular typing tool.

Basmaci R, Bidet P, Yagupsky P, Muñoz-Almagro C, Balashova NV, Doit C, Bonacorsi S.

J Clin Microbiol. 2014 Nov;52(11):3890-7. doi: 10.1128/JCM.01609-14. Epub 2014 Aug 20.

11.

RTX toxin plays a key role in Kingella kingae virulence in an infant rat model.

Chang DW, Nudell YA, Lau J, Zakharian E, Balashova NV.

Infect Immun. 2014 Jun;82(6):2318-28. doi: 10.1128/IAI.01636-14. Epub 2014 Mar 24.

12.

Characterization of TEM-1 β-Lactamase-Producing Kingella kingae Clinical Isolates.

Banerjee A, Kaplan JB, Soherwardy A, Nudell Y, Mackenzie GA, Johnson S, Balashova NV.

Antimicrob Agents Chemother. 2013 Sep;57(9):4300-4306. doi: 10.1128/AAC.00318-13. Epub 2013 Jun 24.

13.

Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.

Brown AC, Balashova NV, Epand RM, Epand RF, Bragin A, Kachlany SC, Walters MJ, Du Y, Boesze-Battaglia K, Lally ET.

J Biol Chem. 2013 Aug 9;288(32):23607-21. doi: 10.1074/jbc.M113.486654. Epub 2013 Jun 21.

14.

Genome sequence of Kingella kingae septic arthritis isolate PYKK081.

Kaplan JB, Lo C, Xie G, Johnson SL, Chain PS, Donnelly R, Kachlany SC, Balashova NV.

J Bacteriol. 2012 Jun;194(11):3017. doi: 10.1128/JB.00421-12.

15.

Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.

Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC.

Toxins (Basel). 2010 Dec;2(12):2824-36. doi: 10.3390/toxins2122824. Epub 2010 Dec 14.

16.

Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide.

Bendaoud M, Vinogradov E, Balashova NV, Kadouri DE, Kachlany SC, Kaplan JB.

J Bacteriol. 2011 Aug;193(15):3879-86. doi: 10.1128/JB.00311-11. Epub 2011 May 20.

17.

Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.

Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M, Le A, Kaur M, Mei Y, Rao J.

Leuk Res. 2010 Jun;34(6):777-85. doi: 10.1016/j.leukres.2009.08.022. Epub 2009 Sep 10.

18.

Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.

Balashova NV, Shah C, Patel JK, Megalla S, Kachlany SC.

Gene. 2009 Aug 15;443(1-2):42-7. doi: 10.1016/j.gene.2009.05.002. Epub 2009 May 18.

PMID:
19450669
19.

A bioluminescent HL-60 cell line to assay anti-leukaemia therapeutics under physiological conditions.

Isaza MP, Chau JT, Le A, Balashova NV, Patel JK, Salerno E, Crosby JA, O'Connor A, Kachlany SC.

Luminescence. 2008 Jan-Feb;23(1):17-21. doi: 10.1002/bio.1010.

PMID:
18167057
20.

Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.

Balashova NV, Park DH, Patel JK, Figurski DH, Kachlany SC.

Infect Immun. 2007 Sep;75(9):4490-7. Epub 2007 Jul 16.

Supplemental Content

Loading ...
Support Center